s6y

4 Acumen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001576885-23-000032

Documents

  1. FORM 4 4
  2. EX-24.1 EX-24.1

On sec.gov